Teva- Pharmaceutical Industries Ltd

NYSE: TEVA
$17.51
-$0.25 (-1.4%)
Closing Price on September 20, 2024

TEVA Articles

US equity markets opened a bit higher this morning, after futures trading pared early morning gains. Early optimism, however, was not to pan out, following some rather downbeat remarks from the...
Jon OggThese are some of the top analyst upgrades, downgrades, and initiations seen from Wall Street research calls this Monday morning. AK Steel Holding Corporation (NYSE: AKS) Raised to Outperform...
We recently gave a full review of the DJIA components we expect to raise their dividend payouts in the weeks and months ahead.  Among those we expect to raise the dividend is Pfizer Inc. (NYSE:...
These are some of the top analyst upgrades, downgrades, and initiations seen from Wall Street research calls this Friday morning. Arch Coal, Inc. (NYSE: ACI) named as Bear of the Day with a $13.00...
Pfizer Inc. (NYSE: PFE) has a big day ahead of it.  While it has been known for years, it is a massive date: Lipitor goes off-patent and will have generic versions of the statin drug competitors....
Paulson & Co. Inc. is another hedge fund group that investors use for Whale Watching, although this last quarter was not exactly kind to Mr. Paulson’s billions… The current 13F report shows...
Each morning 24/7 Wall St. issues a summary list of key analyst upgrades, downgrades, and initiations issued by Wall Street research firms.  We review these calls and other calls made throughout the...
These are some of Tuesday’s top analyst upgrades, downgrades, and initiations seen from Wall Street research calls. Aixtron SE (NASDAQ: AIXG) Raised to Equalweight at Morgan Stanley. Alcatel-Lucent...
These are some of Thursday’s top analyst upgrades, downgrades, and initiations seen from Wall Street research calls. Annaly Capital Management, Inc. (NYSE: NLY) Raised to Outperform at Wells...
These are some of this Monday’s top analyst upgrades, downgrades, and initiations seen from Wall Street research calls this morning. Aetna Inc. (NYSE: AET) added to Strong Buy List at Zacks....
This last week was a bad end to a bad quarter and the research calls were very mixed.  We went through the numerous upgrades and downgrades to identify which calls were insightful as well as to...
These are some of this Wednesday’s top analyst upgrades, downgrades, and initiations seen having an impact from Wall Street research calls. Apple Inc. (NASDAQ: AAPL) Started as Buy with $495 target...